{
    "2019-10-09": [
        [
            {
                "time": "2018-03-29",
                "original_text": "J&J Ordered by Philadelphia Jury to Pay $8B in Risperdal Case",
                "features": {
                    "keywords": [
                        "J&J",
                        "Philadelphia Jury",
                        "Pay",
                        "$8B",
                        "Risperdal Case"
                    ],
                    "sentiment_score": -0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2019-07-15",
                "original_text": "Gilead (GILD) Files NDA for RA Candidate Filgotinib in Japan",
                "features": {
                    "keywords": [
                        "Gilead",
                        "NDA",
                        "RA Candidate",
                        "Filgotinib",
                        "Japan"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-09-12",
                "original_text": "AbbVie Announces New Data from its Dermatology Portfolio and Pipeline at the 28th European Academy of Dermatology and Venereology (EADV) Congress",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "Dermatology Portfolio",
                        "Pipeline",
                        "EADV Congress"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals",
                        "dermatology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}